Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released May 7, 2015, after the close
10-Q filed May 7, 2015, 37 days after period end · 0001104659-15-035590
Q1 2015 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.21-$0.21N/M vs Q1 2014 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q4 2014
Operating Income-$18,241,000N/M Operating Cash Flow$17,987,000N/M Free Cash Flowderived$17,955,000N/M ended Mar 31, 2015 · filed May 7, 2015 · 37 d after period end
10.5% from the close of May 6, 2015 to the close of May 8, 2015, the first after the release.
after the close$4.18$3.74 Mar 31May 7Jun 15